These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15119031)

  • 1. Preventive aspects of specific immunotherapy.
    Jacobsen L
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2003; (94):141-5. PubMed ID: 15119031
    [No Abstract]   [Full Text] [Related]  

  • 2. How strong is the evidence that immunotherapy in children prevents the progression of allergy and asthma?
    Jacobsen L; Valovirta E
    Curr Opin Allergy Clin Immunol; 2007 Dec; 7(6):556-60. PubMed ID: 17989534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy for the prevention of allergic diseases.
    Jacobsen L
    Clin Allergy Immunol; 2004; 18():529-40. PubMed ID: 15042933
    [No Abstract]   [Full Text] [Related]  

  • 4. Further marches: allergic and non-allergic.
    Scadding GK
    Clin Exp Allergy; 2007 Apr; 37(4):485-7. PubMed ID: 17430343
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety and efficacy of allergen immunotherapy in the treatment of allergic rhinitis and asthma in real life.
    Zeldin Y; Weiler Z; Magen E; Tiosano L; Kidon MI
    Isr Med Assoc J; 2008 Dec; 10(12):869-72. PubMed ID: 19160945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sublingual immunotherapy for children: Are we there yet? Defining its role in clinical practice.
    Campbell DE
    Paediatr Respir Rev; 2009 Jun; 10(2):69-74; quiz 74. PubMed ID: 19410205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New visions in specific immunotherapy in children: an iPAC summary and future trends.
    Halken S; Lau S; Valovirta E
    Pediatr Allergy Immunol; 2008 Aug; 19 Suppl 19():60-70. PubMed ID: 18665964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy: first do no harm.
    Moss MH
    Immunol Allergy Clin North Am; 2005 May; 25(2):421-39, viii. PubMed ID: 15878464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sublingual immunotherapy: where do we stand? Present and future.
    Passalacqua G; Pawankar R; Baena-Cagnani CE; Canonica GW
    Curr Opin Allergy Clin Immunol; 2009 Feb; 9(1):1-3. PubMed ID: 19106697
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of allergen-specific immunotherapy on polymorphonuclear leukocyte functions in patients with seasonal allergic rhinitis.
    Soyoğul Gürer U; Büyüköztürk S; Palandüz S; Rayaman E; Colakoglu B; Cevikbaş A
    Int Immunopharmacol; 2005 Apr; 5(4):661-6. PubMed ID: 15710335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The connection between allergic rhinitis and bronchial asthma.
    Corren J
    Curr Opin Pulm Med; 2007 Jan; 13(1):13-8. PubMed ID: 17133119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy, can we improve it?
    Waldbott GL
    Ann Allergy; 1980 Jul; 45(1):56-8. PubMed ID: 7406243
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of six years allergen immunotherapy in allergic rhinitis and allergic asthma.
    Farid R; Ghasemi R; Baradaran-Rahimi M; Jabbari F; Ghaffari J; Rafatpanah H
    Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):29-31. PubMed ID: 17242501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New allergy intervention strategies: hitting the mucosal road.
    Wiedermann U; Mercenier A
    Clin Exp Allergy; 2007 Apr; 37(4):473-5. PubMed ID: 17430341
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacoeconomic assessment of specific immunotherapy versus current symptomatic treatment for allergic rhinitis and asthma in France.
    Omnes LF; Bousquet J; Scheinmann P; Neukirch F; Jasso-Mosqueda G; Chicoye A; Champion L; Fadel R
    Eur Ann Allergy Clin Immunol; 2007 May; 39(5):148-56. PubMed ID: 17626329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, controlled study of specific immunotherapy in monosensitized subjects with seasonal rhinitis: effect on bronchial hyperresponsiveness, sputum inflammatory markers and development of asthma symptoms.
    Crimi N; Li Gotti F; Mangano G; Paolino G; Mastruzzo C; Vancheri C; Lisitano N; Polosa R
    Ann Ital Med Int; 2004; 19(2):98-108. PubMed ID: 15317270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Strategies for the prevention and treatment of allergies in children and adolescents].
    Schröter C
    MMW Fortschr Med; 2004 Dec; 146(50):40-2, 44. PubMed ID: 15658520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
    Kopp MV; Hamelmann E; Zielen S; Kamin W; Bergmann KC; Sieder C; Stenglein S; Seyfried S; Wahn U;
    Clin Exp Allergy; 2009 Feb; 39(2):271-9. PubMed ID: 19016798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
    Halken S
    Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A traditional farming environment--a prophylactic factor against allergies].
    von Mutius E
    Dtsch Med Wochenschr; 2000 Aug; 125(31-32):923. PubMed ID: 10967954
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.